Mandate

Vinge advises owners of petrol company din-X in connection with divestment

Vinge acted as local counsel to the owners of the Scandinavian petrol company din-X in connection with the sale of the company to the Norweigan private equity fund Pioneer Capital.

The company was formed in 1961 as a Swedish counterpart to the Danish petrol company Uno-X. Din-X has had Danish owners since its formation 60 years ago, and the sellers of the company are the descendants of the original founders of Uno-X and din-X. Din-X is headquartered in Helsingborg and operates just below 200 petrol stations with an annual revenue in excess of SEK 1.5bn.

Accura acted as lead counsel. The Vinge team includes Christina Kokko, Maria Dahlin Kolvik and Mikaela Falkner (M&A) and Thomas Sjöberg (Environment).

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026